Isadora S. Fortes
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing Sarcoma.
Journal: Archiv der Pharmazie
Published: September 24, 2025
8-Hydroxyquinoline Derivatives as Drug Candidates for the Treatment of Alzheimer's Disease.
Journal: Current medicinal chemistry
Published: May 12, 2025
Identification of antimycobacterial 8-hydroxyquinoline derivatives as in vitro enzymatic inhibitors of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase.
Journal: Bioorganic chemistry
Published: May 08, 2024
Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials.
Journal: Pharmacological research
Published: June 28, 2022
Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 31, 2021
Modulation of peptidases by 2,4-diamine-quinazoline derivative induces cell death in the amitochondriate parasite Trichomonas vaginalis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 20, 2020
N4 -benzyl-N2 -phenylquinazoline-2,4-diamine compound presents antibacterial and antibiofilm effect against Staphylococcus aureus and Staphylococcus epidermidis.
Journal: Chemical biology & drug design
Published: December 27, 2019
Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.
Journal: European journal of medicinal chemistry
Published: March 18, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026